echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Announcement of the State Food and Drug Administration on the revision of the drug inserts of 14 varieties including paracetamol and Mami Oral Solution (No. 57 of 2021)

    Announcement of the State Food and Drug Administration on the revision of the drug inserts of 14 varieties including paracetamol and Mami Oral Solution (No. 57 of 2021)

    • Last Update: 2021-07-08
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com


    In order to further protect the safety of public medication, the National Medical Products Administration has decided to treat paracetamol and acetaminophen, acetaminophen and acetaminophen syrup, pediatric paracetamol granules, paracetamol and pseudoephedrine chewable tablets, pediatric compound paracetamol tablets, and pediatric ammonia Kahuangmin Granules, Aminojinjinmin Granules, Aminocayumin Solution, Children's Compound Paracetamol and Renin Tablets, Aminocahuangmin Oral Solution, Paracetamol and Pseudoephedrine Dispersible Tablets (Ⅲ), Pediatric Paracetamol and Namin Tablets, Pediatric The drug inserts of 14 varieties including Paracetamol Huang Namin Tablets and Pediatric Paracetamol Huang Namin Granules were revised


    1.


    If the revised content involves the label of a drug, it shall be revised together; the instructions and other content of the label shall be consistent with the original approved content


    2.


    3.


    4.


    5.


    Hereby announce



    Attachment: Requirements for revision of drug inserts for 14 varieties including paracetamol Asami oral solution


    State Food and Drug Administration

    April 21, 2021


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.